Tunisian Lung Cancer Registry
Clinical Observational Study on Tunisian Lung Cancer
This project will track health, treatment, and outcomes for adults in Tunisia who have confirmed lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1334 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Dacima Consulting Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Aryanah and 1 other locations) |
| Trial ID | NCT06934499 on ClinicalTrials.gov |
What this trial studies
This is a prospective, multicenter, national observational registry enrolling adults with histologically or cytologically confirmed lung cancer. Patients are recruited consecutively from pulmonology, medical oncology, radiation oncology, and thoracic surgery departments, and data on clinical features, treatments, and disease course are recorded. Eligibility requires diagnosis confirmed at least three months before inclusion and written informed consent, with no experimental interventions assigned by the registry. The effort is coordinated by Dacima Consulting together with national professional societies and hospital teams to create a representative picture of lung cancer care across Tunisia.
Who should consider this trial
Good fit: Adults over 18 treated in participating Tunisian pulmonology, oncology, radiation oncology, or thoracic surgery departments with histologic or cytologic confirmation of lung cancer who can give informed consent and whose diagnosis occurred at least three months earlier.
Not a fit: Patients diagnosed less than three months ago, those not treated at participating Tunisian centers, or those seeking experimental therapies are unlikely to receive direct benefits from this observational registry.
Why it matters
Potential benefit: If successful, the registry could clarify how lung cancer is diagnosed and treated in Tunisia and help guide improvements in care and resource planning.
How similar studies have performed: Similar national and regional lung cancer registries have provided useful epidemiologic and outcomes data elsewhere, though a prospective multicenter registry specific to Tunisia is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age more than 18 years * Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date * Informed consent Exclusion Criteria: * None
Where this trial is running
Aryanah and 1 other locations
- Tunisian Society of Medical Oncology — Aryanah, Tunisia (Not_yet_recruiting)
- Tunisian Society of Respiratory Diseases and Allergology — Tunis, Tunisia (Recruiting)
Study contacts
- Study coordinator: Soraya Fenniche, MD
- Email: soraya.fenniche@yahoo.fr
- Phone: +216 98 586 490
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.